ישראל - עברית - Ministry of Health

syneron medical - רופא - the lipolite system is intended for dermatological procedures requiring incision, excision, vaporization, ablation and coagulation of soft tissue. the lipolite system is further indicated for laser-assisted lipolysis.

ישראל - עברית - Ministry of Health

syneron medical - אחר - the co2re system is indicated for use in the performance of dermatological procedures requiring ablation, coagulation and resurfacing of soft tissue, including skin.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - methylprednisolone as sodium succinate - אבקה להמסה להזרקה\אינפוזיה - methylprednisolone as sodium succinate 62.5 mg/ml - methylprednisolone - methylprednisolone - antiinflammatory treatment, imumnosuppressive treatment, treatment of hematological and oncological disorders, shock states, endocrine disorders as detailed in the leaflet.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - methylprednisolone as sodium succinate - אבקה להמסה להזרקה\אינפוזיה - methylprednisolone as sodium succinate 62.5 mg/ml - methylprednisolone - methylprednisolone - antiinflammatory treatment, imumnosuppressive treatment, treatment of hematological and oncological disorders, shock states, endocrine disorders as detailed in the leaflet.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - zidovudine - תמיסה לאינפוזיה - zidovudine 200 mg / 20 ml - zidovudine - zidovudine - retrovir iv for infusion is indicated for the short term management of serious manifestations of human immunodeficiency virus (hiv) infection in patients with acquired immuno deficiency syndrome (aids) or aids related complex (arc) who are unable to take retrovir oral formulations.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - methylprednisolone acetate - תרחיף להזרקה - methylprednisolone acetate 40 mg/ml - methylprednisolone - methylprednisolone - for the treatment of conditions responsive to steroid injection therapy.

ישראל - עברית - Ministry of Health

a.veterinary supply ltd - prednisolone 5 mg - tablets - for use in dogs and cats: - rheumatological/orthopaedic disorders: rheumatoid arthritis arthritis deformans bursitis tendinitis periarthritis. - respiratory disorders allergic bronchitis. - gastroenterological disorders chronic active hepatitis. - ophthalmological disorders disorders of the posterior optical segment such as chorioretinitis papillitis optic neuritis. -dermatological disorders anti-inflammatory: pyotraumatic dermatitis allergic dermatitis contact dermatitis urticaria idiopathic seborrhoeic dermatitis acral lick dermatitis juvenile cellulitis. - immunosuppressive lupus erythematosus.

ישראל - עברית - Ministry of Health

a.veterinary supply ltd - prednisolone 50 mg - tablets - for use in dogs and cats: - rheumatological/orthopaedic disorders: rheumatoid arthritis arthritis deformans bursitis tendinitis periarthritis. - respiratory disorders allergic bronchitis. - gastroenterological disorders chronic active hepatitis. - ophthalmological disorders disorders of the posterior optical segment such as chorioretinitis papillitis optic neuritis. -dermatological disorders anti-inflammatory: pyotraumatic dermatitis allergic dermatitis contact dermatitis urticaria idiopathic seborrhoeic dermatitis acral lick dermatitis juvenile cellulitis. - immunosuppressive lupus erythematosus.

ישראל - עברית - Ministry of Health

megapharm ltd - prednisolone - סירופ - prednisolone 3 mg / 1 ml - prednisolone - prednisolone - for glucocorticoid respousive inflamination as: endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states and gastrointestinal diseases.

ישראל - עברית - Ministry of Health

megapharm ltd - palifermin 6.25 mg/vial - solution for injection - palifermin - kepivance is indicated to decrease the incidence, duration and severity of oral mucositis in patients with haematological malignancies receiving myeloablative therapy associated with a high incidence of severe mucositis and requiring autologous haemopoietic stem cell support.